The effect of training variations on the 24 h urinary cortisol/cortisone (C/Cn) ratio and the epinephrine/norepinephrine (E/NE) ratio in relation with mood (evaluated using the Brunel Mood Scale: BRUMS) and performance was investigated in seven trained young female tennis players (12.8 +/- 1.7 years). Like the proposed model in adults, the monitoring of hormonal and mood parameters could be a useful index in training follow-up in young sportswomen. Assessment of nutritional intake, nitrogen excretion rate and nitrogen balance were also determined to measure the dietary practice of these athletes. Nitrogen balance was calculated from the mean daily protein intake and the urinary nitrogen excretion. Data were collected after a 1-month rest (September, T1), 3 months after T1 (after technical and endurance training: December, T2) and 7 months after T1 (after 4 months of increasing-volume/high-intensity training: March, T3). A significant increase in C/Cn ratio (+ 30 %, p < 0.05) were noted from T1 to T3. In the same time, urinary NE concentrations decreased significantly. The E/NE ratio increased from T1 to T2 and decreased at T3 (T1 vs. T3: - 30 %, p < 0.05). The BRUMS inventory at T3 reflected changes in specific mood states with a significant increase in fatigue and anger scores, while vigor scores decreased significantly compared to T1. This period also corresponded with the lowest percentage of matches won and with the highest training load. Energy intake was about 16 % lower than the French recommendations for girls of the same age. However, a positive nitrogen balance was observed from a mean intake of 1.0 g x kg (-1) x day (-1). Our results reveal that an increase of overnight urinary C/Cn ratio and a decrease of E/NE ratio are concomitant with alterations in mood state and performance, all these parameters being associated with physical and psychological stress.

No abstract

No abstract

No abstract

Neonatal hypoxia-ischemia (nHI) is a major cause of death or subsequent disabilities in infants. Hypoxia-ischemia causes brain lesions, which are induced by a strong reduction in oxygen and nutrient supply. Hypothermia is the only validated beneficial intervention, but not all newborns respond to it and today no pharmacological treatment exists. Among possible therapeutic agents to test, trans-resveratrol is an interesting candidate as it has been reported to exhibit neuroprotective effects in some neurodegenerative diseases. This experimental study aimed to investigate a possible neuroprotection by resveratrol in rat nHI, when administered to the pregnant rat female, at a nutritional dose. Several groups of pregnant female rats were studied in which resveratrol was added to drinking water either during the last week of pregnancy, the first week of lactation, or both. Then, 7-day old pups underwent a hypoxic-ischemic event. Pups were followed longitudinally, using both MRI and behavioral testing. Finally, a last group was studied in which breastfeeding females were supplemented 1 week with resveratrol just after the hypoxic-ischemic event of the pups (to test the curative rather than the preventive effect). To decipher the molecular mechanisms of this neuroprotection, RT-qPCR and Western blots were also performed on pup brain samples. Data clearly indicated that when pregnant and/or breastfeeding females were supplemented with resveratrol, hypoxic-ischemic offspring brain lesions were significantly reduced. Moreover, maternal resveratrol supplementation allowed to reverse sensorimotor and cognitive deficits caused by the insult. The best recoveries were observed when resveratrol was administered during both gestation and lactation (2 weeks before the hypoxic-ischemic event in pups). Furthermore, neuroprotection was also observed in the curative group, but only at the latest stages examined. Our hypothesis is that resveratrol, in addition to the well-known neuroprotective benefits via the sirtuin’s pathway (antioxidant properties, inhibition of apoptosis), has an impact on brain metabolism, and more specifically on the astrocyte-neuron lactate shuttle (ANLS) as suggested by RT-qPCR and Western blot data, that contributes to the neuroprotective effects.